Zohar Koren
Directeur Général chez SciCann Therapeutics, Inc.
Profil
Zohar Koren was the founder of Cannabics, Inc. (2012), CNBX Pharmaceuticals, Inc. (2014), and Xinteza API Ltd.
(2019) where he held the titles of Chief Executive Officer & Director (2014-2015) and Chief Technology Officer (2019-present).
Dr. Koren is also the founder of SciCann Therapeutics, Inc. He previously worked as a Director at Alterola Biotech, Inc. Dr. Koren received his undergraduate degree from The Hebrew University of Jerusalem and his graduate and doctorate degrees from the University of Haifa.
Postes actifs de Zohar Koren
| Sociétés | Poste | Début |
|---|---|---|
SciCann Therapeutics, Inc.
 SciCann Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology SciCann Therapeutics, Inc. develops pharmaceuticals. The Canadian company was founded by Zohar Koren. Zohar Koren has been the CEO since incorporation. | Directeur Général | - |
Xinteza API Ltd.
 Xinteza API Ltd. Pharmaceuticals: OtherHealth Technology Xinteza Ltd. is developing proprietary technologies related to the production of cannabinoid-based active pharmaceutical ingredients for pharmaceutical and food industries. The company was founded by Alon Gal on March 17, 2019 and is headquartered in Tel Aviv, Israel. | Fondateur | 17/03/2019 |
Anciens postes connus de Zohar Koren
| Sociétés | Poste | Fin |
|---|---|---|
| CNBX PHARMACEUTICALS INC. | Fondateur | 23/01/2015 |
| ALTEROLA BIOTECH, INC. | Directeur/Membre du Conseil | - |
Cannabics, Inc.
 Cannabics, Inc. Financial ConglomeratesFinance Cannabics, Inc. provides cannabinoid-based therapy solutions. The firm specializes in molecular biology, cancer research and pharmacology. The company was founded by Itamar Borochov, Eyal Ballan and Zohar Koren on December 7, 2012 and is headquartered in Wilmington, DE. | Fondateur | - |
Formation de Zohar Koren
| The Hebrew University of Jerusalem | Undergraduate Degree |
| University of Haifa | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CNBX PHARMACEUTICALS INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Alterola Biotech, Inc. (California)
 Alterola Biotech, Inc. (California) Chemicals: SpecialtyProcess Industries Alterola Biotech, Inc. is a development stage company. It engages in the development of chewing gums for the delivery of nutraceutical and functional ingredients for applications such as appetite suppressant, cholesterol suppressant, vitamin delivery, antioxidant delivery, and motion sickness suppressant. The company was founded on July 21, 2008 and is headquartered in Walnut, CA. | Process Industries |
Cannabics, Inc.
Cannabics, Inc. Financial ConglomeratesFinance Cannabics, Inc. provides cannabinoid-based therapy solutions. The firm specializes in molecular biology, cancer research and pharmacology. The company was founded by Itamar Borochov, Eyal Ballan and Zohar Koren on December 7, 2012 and is headquartered in Wilmington, DE. | Finance |
Xinteza API Ltd.
Xinteza API Ltd. Pharmaceuticals: OtherHealth Technology Xinteza Ltd. is developing proprietary technologies related to the production of cannabinoid-based active pharmaceutical ingredients for pharmaceutical and food industries. The company was founded by Alon Gal on March 17, 2019 and is headquartered in Tel Aviv, Israel. | Health Technology |
SciCann Therapeutics, Inc.
SciCann Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology SciCann Therapeutics, Inc. develops pharmaceuticals. The Canadian company was founded by Zohar Koren. Zohar Koren has been the CEO since incorporation. | Health Technology |
